Literature DB >> 7747447

Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.

J Vlach1, A Garcia, J M Jacqué, M S Rodriguez, S Michelson, J L Virelizier.   

Abstract

In contrast to the purely enhancer-dependent effect of cytokines such as TNF on the activity of the HIV regulatory region (LTR), we observed that okadaic acid (OKA) activates HIV transcription through both the enhancer, responding to the factor NF-kappa B, and the promoter domain of the LTR. The inducibility of HIV LTR-driven luciferase expression constructs in lymphoblastoid cells stimulated by OKA depended on both functional Sp1 binding elements and the ability of the TATA box to bind the protein TBP. In both transformed and normal lymphocytes, OKA stimulation induced intense phosphorylation of the constitutively expressed Sp1 protein in the nucleus, a property of OKA not shared by TNF, phorbol ester, or PHA and interleukin 2. Responsiveness of LTR constructs deleted of kappa B elements to HIV Tat expression was increased upon OKA but not TNF stimulation. Our results suggest that SP1 phosphorylation induced by OKA, a selective inhibitor of the serine-threonine phosphatase PP2A, facilitates the formation of a transcription complex involving general transcription factors, HIV Tat, and Sp1 proteins. The formation of this complex would increase, independently of an in synergy with NF-kappa B, the low basal activity of the HIV LTR observed in normal T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7747447     DOI: 10.1006/viro.1995.1207

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  Shear stress induction of the tissue factor gene.

Authors:  M C Lin; F Almus-Jacobs; H H Chen; G C Parry; N Mackman; J Y Shyy; S Chien
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

3.  Functional interference of Sp1 and NF-kappaB through the same DNA binding site.

Authors:  F Hirano; H Tanaka; Y Hirano; M Hiramoto; H Handa; I Makino; C Scheidereit
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

4.  Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes.

Authors:  J M Jacqué; B Fernández; F Arenzana-Seisdedos; D Thomas; F Baleux; J L Virelizier; F Bachelerie
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor.

Authors:  G Z Yan; E B Ziff
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

6.  TNF-alpha downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding.

Authors:  L A Denson; R K Menon; A Shaufl; H S Bajwa; C R Williams; S J Karpen
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 7.  Curing HIV: Pharmacologic approaches to target HIV-1 latency.

Authors:  Shailesh K Choudhary; David M Margolis
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

8.  Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription.

Authors:  M C Estable; B Bell; M Hirst; I Sadowski
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  Post-translational control of sp-family transcription factors.

Authors:  J S Waby; C D Bingle; B M Corfe
Journal:  Curr Genomics       Date:  2008       Impact factor: 2.236

Review 10.  Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.

Authors:  Evelyn M Kilareski; Sonia Shah; Michael R Nonnemacher; Brian Wigdahl
Journal:  Retrovirology       Date:  2009-12-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.